Literature DB >> 12717444

Translokin is an intracellular mediator of FGF-2 trafficking.

Carine Bossard1, Henrik Laurell, Loïc Van den Berghe, Sylvain Meunier, Catherine Zanibellato, Hervé Prats.   

Abstract

Basic fibroblast growth factor (bFGF or FGF-2) exerts its pleiotropic activities both as an exogenous and an intracellular factor. FGF-1 and FGF-2 are prototypes for this dual signalling, but the mechanisms of their intracellular actions remain unknown. Here we show that Translokin, a cytoplasmic protein of relative molecular mass 55,000 (M(r) 55K), interacts specifically with the 18K form of FGF-2. Translokin is ubiquitously expressed and colocalizes with the microtubular network. As Translokin does not interact with FGF-1, we used a strategy based on FGF-1-FGF-2 chimaeras to map the interacting regions in FGF-2 and to generate Nb1a2, a non-interacting variant of FGF-2. Although most of the FGF-2 properties are preserved in Nb1a2, this variant is defective in intracellular translocation and in stimulating proliferation. The fusion of a nuclear localization signal to Nb1a2 restores its mitogenic activity and its nuclear association. Inhibiting Translokin expression by RNA interference reduces the translocation of FGF-2 without affecting the intracellular trafficking of FGF-1. Our data show that the nuclear association of internalized FGF-2 is essential for its mitogenic activity and that Translokin is important in this translocation pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12717444     DOI: 10.1038/ncb979

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  19 in total

1.  Cep57, a NEDD1-binding pericentriolar material component, is essential for spindle pole integrity.

Authors:  Qixi Wu; Runsheng He; Haining Zhou; Albert C H Yu; Bo Zhang; Junlin Teng; Jianguo Chen
Journal:  Cell Res       Date:  2012-04-17       Impact factor: 25.617

Review 2.  CEP proteins: the knights of centrosome dynasty.

Authors:  Ambuj Kumar; Vidya Rajendran; Rao Sethumadhavan; Rituraj Purohit
Journal:  Protoplasma       Date:  2013-02-28       Impact factor: 3.356

3.  Cep57 protein is required for cytokinesis by facilitating central spindle microtubule organization.

Authors:  Runsheng He; Qixi Wu; Haining Zhou; Ning Huang; Jianguo Chen; Junlin Teng
Journal:  J Biol Chem       Date:  2013-04-08       Impact factor: 5.157

Review 4.  A nuclear odyssey: fibroblast growth factor-2 (FGF-2) as a regulator of nuclear homeostasis in the nervous system.

Authors:  Benjamin Förthmann; Claudia Grothe; Peter Claus
Journal:  Cell Mol Life Sci       Date:  2015-01-01       Impact factor: 9.261

5.  The FGF2-binding peptide P7 inhibits melanoma growth in vitro and in vivo.

Authors:  Yonglin Yu; Susu Gao; Quchou Li; Cong Wang; Xinqiang Lai; Xilei Chen; Ruixue Wang; Jingfang Di; Tao Li; Wenhui Wang; Xiaoping Wu
Journal:  J Cancer Res Clin Oncol       Date:  2012-04-06       Impact factor: 4.553

Review 6.  High molecular weight FGF2: the biology of a nuclear growth factor.

Authors:  K Chlebova; V Bryja; P Dvorak; A Kozubik; W R Wilcox; P Krejci
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

7.  Translocation of FGF-1 and FGF-2 across vesicular membranes occurs during G1-phase by a common mechanism.

Authors:  Jedrzej Małecki; Jørgen Wesche; Camilla Skiple Skjerpen; Antoni Wiedłocha; Sjur Olsnes
Journal:  Mol Biol Cell       Date:  2003-12-02       Impact factor: 4.138

8.  Cep57, a multidomain protein with unique microtubule and centrosomal localization domains.

Authors:  Ko Momotani; Alexander S Khromov; Tsuyoshi Miyake; P Todd Stukenberg; Avril V Somlyo
Journal:  Biochem J       Date:  2008-06-01       Impact factor: 3.857

9.  Fibroblast growth factor-2(23) binds directly to the survival of motoneuron protein and is associated with small nuclear RNAs.

Authors:  Peter Claus; Alexander-Francisco Bruns; Claudia Grothe
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

Review 10.  Fibroblast growth factor-2 and cardioprotection.

Authors:  Elissavet Kardami; Karen Detillieux; Xin Ma; Zhisheng Jiang; Jon-Jon Santiago; Sarah K Jimenez; Peter A Cattini
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.